Kristopher Hanson
CIK: 0001789970
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
MapLight Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (24 total)
- Oct 15, 2026MPLT
MapLight Therapeutics, Inc.
Sale(S)Direct9K shares at avg. $8.08$73K - Sep 16, 2026MPLT
MapLight Therapeutics, Inc.
Sale(S)Direct16.5K shares at avg. $11.67$193K - Aug 17, 2026MPLT
MapLight Therapeutics, Inc.
Award(A)Direct7.7K shares- - Jul 17, 2026MPLT
MapLight Therapeutics, Inc.
Sale(S)Direct1.1K shares at avg. $37.90$43K - Jul 16, 2026MPLT
MapLight Therapeutics, Inc.
Sale(S)Direct11 shares at avg. $37.96$417.56 - Jul 16, 2026MPLT
MapLight Therapeutics, Inc.
Sale(S)Direct3.3K shares at avg. $37.26$124K - Jul 16, 2026MPLT
MapLight Therapeutics, Inc.
Sale(S)Direct4.8K shares at avg. $36.45$174K - Jul 15, 2026MPLT
MapLight Therapeutics, Inc.
Sale(S)Direct2.1K shares at avg. $36.00$77K - Jul 15, 2026MPLT
MapLight Therapeutics, Inc.
Sale(S)Direct5.1K shares at avg. $36.99$189K - Jul 15, 2026MPLT
MapLight Therapeutics, Inc.
Sale(S)Direct10 shares at avg. $37.54$375.4 - May 11, 2026MPLT
MapLight Therapeutics, Inc.
Sale(S)Direct7K shares at avg. $30.04$210K - May 11, 2026MPLT
MapLight Therapeutics, Inc.
Sale(S)Direct5.8K shares at avg. $30.56$177K - May 11, 2026MPLT
MapLight Therapeutics, Inc.
Sale(S)Direct284 shares at avg. $27.61$8K - May 11, 2026MPLT
MapLight Therapeutics, Inc.
Sale(S)Direct846 shares at avg. $28.70$24K - May 4, 2026MPLT
MapLight Therapeutics, Inc.
Sale(S)Direct9K shares at avg. $27.50$248K - May 4, 2026MPLT
MapLight Therapeutics, Inc.
Sale(S)Direct296 shares at avg. $29.56$9K - May 4, 2026MPLT
MapLight Therapeutics, Inc.
Sale(S)Direct3.9K shares at avg. $28.29$111K - May 4, 2026MPLT
MapLight Therapeutics, Inc.
Sale(S)Direct683 shares at avg. $30.08$21K - Apr 16, 2026MPLT
MapLight Therapeutics, Inc.
Sale(S)Direct225 shares at avg. $27.49$6K - Apr 16, 2026MPLT
MapLight Therapeutics, Inc.
Sale(S)Direct73 shares at avg. $27.01$2K - Apr 15, 2026MPLT
MapLight Therapeutics, Inc.
Sale(S)Direct1.5K shares at avg. $26.80$41K - Feb 5, 2026MPLT
MapLight Therapeutics, Inc.
Award(A)Direct7.7K shares- - Jan 27, 2026MPLT
MapLight Therapeutics, Inc.
Tax Payment(F)Direct26K shares at avg. $17.98$468K - Oct 27, 2025MPLT
MapLight Therapeutics, Inc.
Award(A)Direct27.1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 15, 2026 | MPLT MapLight Therapeutics, Inc. | Sale(S) | 9,020 | $8.08 | $72,882 | Direct |
| Sep 16, 2026 | MPLT MapLight Therapeutics, Inc. | Sale(S) | 16,509 | $11.67 | $192,660 | Direct |
| Aug 17, 2026 | MPLT MapLight Therapeutics, Inc. | Award(A) | 7,730 | - | $0 | Direct |
| Jul 17, 2026 | MPLT MapLight Therapeutics, Inc. | Sale(S) | 1,130 | $37.90 | $42,827 | Direct |
| Jul 16, 2026 | MPLT MapLight Therapeutics, Inc. | Sale(S) | 11 | $37.96 | $418 | Direct |
| Jul 16, 2026 | MPLT MapLight Therapeutics, Inc. | Sale(S) | 3,331 | $37.26 | $124,113 | Direct |
| Jul 16, 2026 | MPLT MapLight Therapeutics, Inc. | Sale(S) | 4,776 | $36.45 | $174,085 | Direct |
| Jul 15, 2026 | MPLT MapLight Therapeutics, Inc. | Sale(S) | 2,147 | $36.00 | $77,292 | Direct |
| Jul 15, 2026 | MPLT MapLight Therapeutics, Inc. | Sale(S) | 5,103 | $36.99 | $188,760 | Direct |
| Jul 15, 2026 | MPLT MapLight Therapeutics, Inc. | Sale(S) | 10 | $37.54 | $375 | Direct |
| May 11, 2026 | MPLT MapLight Therapeutics, Inc. | Sale(S) | 6,979 | $30.04 | $209,649 | Direct |
| May 11, 2026 | MPLT MapLight Therapeutics, Inc. | Sale(S) | 5,808 | $30.56 | $177,492 | Direct |
| May 11, 2026 | MPLT MapLight Therapeutics, Inc. | Sale(S) | 284 | $27.61 | $7,841 | Direct |
| May 11, 2026 | MPLT MapLight Therapeutics, Inc. | Sale(S) | 846 | $28.70 | $24,280 | Direct |
| May 4, 2026 | MPLT MapLight Therapeutics, Inc. | Sale(S) | 9,030 | $27.50 | $248,325 | Direct |
| May 4, 2026 | MPLT MapLight Therapeutics, Inc. | Sale(S) | 296 | $29.56 | $8,750 | Direct |
| May 4, 2026 | MPLT MapLight Therapeutics, Inc. | Sale(S) | 3,908 | $28.29 | $110,557 | Direct |
| May 4, 2026 | MPLT MapLight Therapeutics, Inc. | Sale(S) | 683 | $30.08 | $20,545 | Direct |
| Apr 16, 2026 | MPLT MapLight Therapeutics, Inc. | Sale(S) | 225 | $27.49 | $6,185 | Direct |
| Apr 16, 2026 | MPLT MapLight Therapeutics, Inc. | Sale(S) | 73 | $27.01 | $1,972 | Direct |
| Apr 15, 2026 | MPLT MapLight Therapeutics, Inc. | Sale(S) | 1,529 | $26.80 | $40,977 | Direct |
| Feb 5, 2026 | MPLT MapLight Therapeutics, Inc. | Award(A) | 7,730 | - | $0 | Direct |
| Jan 27, 2026 | MPLT MapLight Therapeutics, Inc. | Tax Payment(F) | 26,007 | $17.98 | $467,606 | Direct |
| Oct 27, 2025 | MPLT MapLight Therapeutics, Inc. | Award(A) | 27,098 | - | - | Direct |
1-24 of 24 transactions
About Hanson Kristopher
Hanson Kristopher (SEC CIK 0001789970) files insider reports with the SEC as General Counsel of MapLight Therapeutics, Inc. (MPLT).
Signal8 holds 11 ownership filings by Hanson Kristopher (1 Form 3, 10 Form 4), filed between Oct 27, 2025 and Oct 16, 2026. Those filings report 24 transactions, from Oct 27, 2025 to Oct 15, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Hanson Kristopher's filings is in REDWOOD CITY, CA.
Recent filings by Hanson Kristopher
- Oct 15, 2026: Open-market sale of MPLT shares (Form 4, code S).
- Sep 16, 2026: Open-market sale of MPLT shares (Form 4, code S).
- Aug 17, 2026: Grant or award of MPLT shares (Form 4, code A).
- Jul 17, 2026: Open-market sale of MPLT shares (Form 4, code S).
- Jul 16, 2026: Open-market sales of MPLT shares (3 lines, Form 4, code S).
Other insiders filing for MapLight Therapeutics, Inc. (MPLT)
- Kreitzer Anatol, Chief Discovery Officer
- GILLIS JONATHAN, CAO and Interim CFO
- Lillie James Woodruff, Chief Scientific Officer
- Foff Erin Pennock, Chief Medical Officer
- Kroeger Christopher A., Chief Executive Officer
- Cox Troy, Director